Pacemaker Implantation in Juvenile Neuronal Ceroid Lipofuscinosis (CLN3)-A Long-Term Follow-Up Study.

CLN3 Juvenile Neuronal Ceroid Lipofuscinosis neurodegenerative diseases pacemaker sick sinus syndrome

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2022
Historique:
received: 30 12 2021
accepted: 02 02 2022
entrez: 31 3 2022
pubmed: 1 4 2022
medline: 1 4 2022
Statut: epublish

Résumé

It is well documented that deteriorating heart function due to deposition of ceroid lipopigment is a significant co-morbidity in Juvenile Neuronal Ceroid Lipofuscinosis (CLN3 disease) although the exact disease mechanisms remain unknown in any NCL form. An increasing frequency of cardiac conduction disorders including severe bradycardia and sinus arrest is seen in the late teens, as is a left ventricular hypertrophy in the early 20s. Only a few case reports of pacemaker implantation have been published, and so far, no long-term follow-up study exists. As new treatment options emerge, more patients will live longer and the need for pacemaker will likely increase, why knowledge of long-term outcome is needed. In the present study, we present the course of six patients from the original Danish CLN3-heart population study (

Identifiants

pubmed: 35356463
doi: 10.3389/fneur.2022.846240
pmc: PMC8960059
doi:

Types de publication

Journal Article

Langues

eng

Pagination

846240

Informations de copyright

Copyright © 2022 Handrup, Mølgaard, Andersen and Ostergaard.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Eur Heart J. 1989 Aug;10(8):758-64
pubmed: 2792118
Eur J Paediatr Neurol. 2001;5 Suppl A:213-7
pubmed: 11589001
N Engl J Med. 2018 May 17;378(20):1898-1907
pubmed: 29688815
Neurology. 2011 Apr 5;76(14):1245-51
pubmed: 21464428
Neurology. 2014 Jun 10;82(23):2072-6
pubmed: 24827497
Int J Cardiol. 2014 Jun 1;174(1):143-6
pubmed: 24726208
Epileptic Disord. 2016 Sep 1;18(S2):73-88
pubmed: 27629553
Biochim Biophys Acta Mol Basis Dis. 2020 Sep 1;1866(9):165643
pubmed: 31863828
Eur J Paediatr Neurol. 2013 May;17(3):265-8
pubmed: 23177590
Lancet Neurol. 2019 Jan;18(1):107-116
pubmed: 30470609
J Inherit Metab Dis. 2012 May;35(3):549-55
pubmed: 22167274
Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2237-41
pubmed: 26026925
Biochim Biophys Acta Mol Basis Dis. 2020 Sep 1;1866(9):165681
pubmed: 31926264

Auteurs

Mette Møller Handrup (MM)

Department of Pediatrics and Adolescent Medicine, Centre for Rare Diseases, Aarhus University Hospital, Aarhus, Denmark.

Henning Mølgaard (H)

Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.

Brian N Andersen (BN)

Department of Pediatrics and Adolescent Medicine, Centre for Rare Diseases, Aarhus University Hospital, Aarhus, Denmark.

John R Ostergaard (JR)

Department of Pediatrics and Adolescent Medicine, Centre for Rare Diseases, Aarhus University Hospital, Aarhus, Denmark.

Classifications MeSH